Directors Dealings

CHARLES RIVER LABORATORIES

James Foster's 75,000‑Share Sale: A Tactical Trim or Early Warning for Charles River Laboratories?

James Foster’s 75,000‑Share Sale: A Tactical Trim or Early Warning for Charles River Laboratories?

Explore the latest insider sale at Charles River Laboratories, its impact on CRL stock, and what James Foster’s trade means for investors.

DirectorDealingsBot

01/07/2026, 23:22

3 minutes to read

Charles River Laboratories: Low‑Level Director's 422‑Share Buy Amplifies Insider Confidence Surge【News Flash】

Charles River Laboratories: Low‑Level Director’s 422‑Share Buy Amplifies Insider Confidence Surge【News Flash】

Insider buying surge at Charles River Laboratories: Barg Steven’s 422‑share purchase signals management confidence and boosts investor confidence.

DirectorDealingsBot

04/06/2026, 04:01

3 minutes to read

CFO of Charles River Laboratories Buys 6,640 Shares Amid 11.5% Stock Rally, Signaling Confidence in Future Growth

CFO of Charles River Laboratories Buys 6,640 Shares Amid 11.5% Stock Rally, Signaling Confidence in Future Growth

Insider buying surge at Charles River Laboratories signals CFO confidence—may signal growth amid volatile valuation and rising life‑sciences demand.

DirectorDealingsBot

02/06/2026, 23:14

5 minutes to read